Close Asset Management’s AngioDynamics ANGO Stock Holding History

Close Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,750	Closed	-$39K	–	239
2023 Q2	$39K	Buy	+3,750	New	+$36.1K	﹤0.01%	166

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Close Asset Management's ANGO Position: Q3 2023 in Review

Close Asset Management sold out of AngioDynamics (ANGO) in Q3 2023, closing a stake of 3,750 shares — an estimated $39K sold.

Close Asset Management first reported a position in ANGO in Q2 2023 and held it in 1 quarter. The position peaked at $39K in Q2 2023. 154 funds tracked by Wall St. Rank hold ANGO as of Q3 2023.

Close Asset Management reported no remaining AngioDynamics position as of Q3 2023 after selling out during the quarter.
Close Asset Management sold 3,750 AngioDynamics shares in Q3 2023, an estimated $39K.
Close Asset Management first reported a position in AngioDynamics in Q2 2023 and held it in 1 quarter.
Close Asset Management's AngioDynamics position peaked at $39K in Q2 2023.
154 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2023.

Based on Close Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.